Opus Genetics IRD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$106.93M-82.4% | -$49.59M+13.8% | -$68.2M-151% | -$58.28M-313% | -$58.62M-419% | ||
| $53K+130% | $53K+430% | $50K+1,567% | $37K+825% | $23K+360% | ||
| $3.95M+20.1% | $3.4M+1.1% | $3.42M+4.3% | $3.38M+9.9% | $3.29M-10.9% | ||
| -$38.99M-35.1% | -$35.25M-37.8% | -$32.86M— | -$31.83M— | -$28.85M— | ||
| —— | $0-100% | $302.5K-66.7% | $605K0.0% | $907.5K+200% | ||
| $0-100% | $0-100% | $1.21M— | $1.21M— | $1.21M— | ||
| $57.15M+156% | $50.02M+1,072% | $25.91M+229% | $21.72M+68.5% | $22.36M+96.9% | ||
| —— | —— | —— | —— | -$5.37M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
